The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?
A profound loss of cortical cholinergic innervation is a nearly invariant feature of advanced Alzheimer's disease (AD). The temporal course of this lesion and its relationship to other aspects of the disease have not yet been fully clarified. Despite assertions to the contrary, a review of the evidence suggests that a perturbation of cholinergic innervation is likely to be present even in the very early stages of AD. This cholinergic lesion is unlikely to be a major determinant of the clinical symptoms or of the neuropathological lesions. Nonetheless, it almost certainly contributes to the severity of the cognitive and behavioral deficits, especially in the areas of memory and attention. The cholinergic lesion may also influence the progression of the neuropathological process through complex interactions with amyloidogenesis, tau phosphorylation and neuroplasticity.
Mesulam
Marsel
M
Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA. mmesulam@nwu.edu
D000109:Acetylcholine / Q000378:metabolism*; D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D000818:Animals; D001288:Attention; D001921:Brain / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D002799:Cholinergic Fibers / Q000473:pathology*; D018450:Disease Progression; D006801:Humans; D008568:Memory; D016874:Neurofibrillary Tangles / Q000473:pathology; D009473:Neuronal Plasticity; D010766:Phosphorylation; D058225:Plaque, Amyloid / Q000473:pathology
D000109:Acetylcholine